Literature DB >> 30025919

Vasoactivity of retinal veins: A potential involvement of endothelin-1 (ET-1) in the pathogenesis of retinal vein occlusion (RVO).

Teruyo Kida1, Josef Flammer2, Hidehiro Oku3, Katarzyna Konieczka2, Seita Morishita4, Taeko Horie3, Tsunehiko Ikeda3.   

Abstract

PURPOSE: Whilst the pathogenesis of retinal vein occlusion (RVO) is still unclear, systemic hypertension and increased level of endothelin-1 (ET-1) are known risk factors. Therefore, we studied the influence of ET-1 on the retinal veins in hypertensive rats.
METHODS: We focused on the behavior of retinal veins in spontaneous hypertensive rats (SHR). To determine whether ET-1 was associated with the blood flow in eyes of SHRs, the chorioretinal blood flow in the rats was assessed using laser speckle flowgraphy (LSFG-Micro, Softcare, Fukuoka, Japan) before and after an intravenous injection of ET-1 under general anesthesia. In addition, retinas from SHRs and age-matched normotensive Wistar-Kyoto rats (WKYs) were removed, and retinal sections were immunostained for the ET-A and ET-B receptors. The protein levels of both ET-1 receptors and hypoxia-inducible factor 1 (HIF-1) in the retinal tissues were also determined by western blot analysis.
RESULTS: One of the retinal veins became exceptionally constricted and was nearly occluded, and the chorioretinal blood flow significantly decreased in the retinas of SHRs following the injection of ET-1. Immunoreactivity to ET-A receptor was higher in SHR retinas than in WKY retinas. The protein levels of ET-A receptor and HIF-1 were also significantly higher in SHR retinas than in WKY retinas.
CONCLUSIONS: An increase of ET-1 in circulating blood leads to the local constriction of retinal veins and this effect is accentuated in hypertensive rats by an upregulation of ET-A receptor. It is plausible that such a constriction of retinal veins increases retinal venous pressure, and may even contribute to the pathogenesis of RVO.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30025919     DOI: 10.1016/j.exer.2018.07.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  6 in total

1.  Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion-related macular edema.

Authors:  Teruyo Kida; Josef Flammer; Katarzyna Konieczka; Tsunehiko Ikeda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-15       Impact factor: 3.117

2.  Longitudinal Testing of Retinal Blood Flow in a Mouse Model of Hypertension by Laser Speckle Flowgraphy.

Authors:  Michelle R Tamplin; Kimberly A Broadhurst; Anthony H Vitale; Ryuya Hashimoto; Randy H Kardon; Isabella M Grumbach
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

3.  Effect of temperature-sensitive nanogel combined with angioplasty on sICAM-1 and VE-cadherin in lower extremity arterial occlusion rabbits.

Authors:  Ming Qi; Ze Song; Lei Wang; Xu Xie
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Data on the involvement of endothelin-1 (ET-1) in the dysregulation of retinal veins.

Authors:  Teruyo Kida; Josef Flammer; Hidehiro Oku; Katarzyna Konieczka; Seita Morishita; Taeko Horie; Tsunehiko Ikeda
Journal:  Data Brief       Date:  2018-09-29

5.  Altered Retinal Hemodynamics and Mean Circulation Time in Spontaneously Hypertensive Rats.

Authors:  Wendy Leskova; Ravdeep Warar; Norman R Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

6.  AGEs/RAGE blockade downregulates Endothenin-1 (ET-1), mitigating Human Umbilical Vein Endothelial Cells (HUVEC) injury in deep vein thrombosis (DVT).

Authors:  Yunxin Zhang; Jianlong Liu; Wei Jia; Xuan Tian; Peng Jiang; Zhiyuan Cheng; Jinyong Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.